+ Create post

L’Oréal posts faster sales growth as professional and dermatology brands expand

L’Oréal ($OR-EURONEXT) generated third-quarter 2026 sales of €11.56 billion, up 11.9% as reported and 7.2% like for like. Growth was 7.7% on the company’s adjusted like-for-like measure, which removes sales timing effects associated with its information-technology transformation. Professional Products and Dermatological Beauty each achieved 13.9% growth on that adjusted basis, while Luxe increased 7.0% and Consumer Products rose 3.8%. Nine-month revenue reached €35.34 billion, an increase of 7.7

0
0

L’Oréal faces Arizona lawsuit over hair-relaxer safety claims

Arizona sued L’Oréal ($OR-EURONEXT), alleging that the company concealed cancer risks associated with chemical hair relaxers. The state is seeking remedies including damages, penalties and stronger warnings. The allegations concern products already facing extensive litigation in the United States. L’Oréal disputes the claims and maintains that its products are safe, saying the case lacks scientific and legal merit. The lawsuit is an allegation, not a court finding that the products caused cancer

0
0